UPB
Upstream Bio, Inc.
5.40$
+3.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.5% | +42.2% | -20.3% | +19.0% | +1.0% | -7.7% | +65.5% | -27.1% | -2.2% | +54.8% | -25.2% | – | |
| – | – | – | – | – | +250.0% | -12.2% | +32.6% | -45.6% | +83.9% | -14.0% | – | – | |
| – | -27.5% | +42.2% | -20.3% | +19.0% | +1.0% | -7.7% | +65.5% | -27.1% | -2.2% | +47.5% | -21.5% | – | |
| – | +48.4% | +1.2% | +20.3% | +9.7% | +41.1% | +18.5% | +46.8% | -12.9% | +21.8% | -9.0% | -1.3% | – | |
| – | +45.4% | +22.8% | +0.5% | +2.2% | +26.8% | +31.5% | +9.4% | -25.3% | +20.3% | +21.3% | -12.8% | – | |
| – | +47.7% | +5.9% | +15.3% | +8.0% | +38.1% | +21.0% | +39.0% | -14.9% | +21.6% | -4.8% | -3.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.